HIGHLIGHTS
- who: Andrea Fischer from the University of Glasgow, United Kingdom have published the paper: Pregabalin Add-On vs. Dose Increase in Levetiracetam Add-On Treatment: A Real-Life Trial in Dogs With Drug-Resistant Epilepsy, in the Journal: (JOURNAL)
- what: This study design with an early individual study endpoint was associated with high compliance of dog owners and enabled analysis of all study participants.
- how: The following baseline parameters were calculated longest interseizure interval during baseline (T1) and monthly seizure frequency (MSF) during baseline. It should be noted that long-term follow-up . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.